Theophylline-induced behavior change in children. An objective evaluation of parents' perceptions

B Bender1, H Milgrom

  • 1Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.

JAMA
|May 20, 1992
PubMed

Insights

This study found that theophylline did not cause behavioral side effects in children with asthma as reported by parents. Objective measures showed minimal changes, contradicting parental beliefs about the medication

Area of Science:

  • Pediatric Pulmonology
  • Child Psychology
  • Pharmacology

Background:

  • Theophylline is a medication used to treat asthma in children.
  • Concerns exist regarding potential behavioral side effects of theophylline therapy.
  • Parental reports of side effects like hyperactivity and inattention are common.

Purpose of the Study:

  • To objectively assess behavioral side effects in children treated with theophylline.
  • To determine if parental observations of side effects align with blinded assessments.
  • To investigate the relationship between theophylline levels and behavioral changes.

Main Methods:

  • A double-blind, placebo-controlled, randomized crossover study was conducted.
  • Children aged 8-12 with asthma participated.
  • Evaluations included objective cognitive/behavioral tests and parental rating scales.

Main Results:

  • No significant differences in behavior were detected via parent questionnaires or most psychological tests.
  • Children showed slightly improved attention but increased mild anxiety and hand tremor while on theophylline.
  • No correlation was found between serum theophylline levels and behavioral changes.

Conclusions:

  • Parental beliefs regarding theophylline's behavioral side effects were not supported by blinded observations.
  • Objective assessments contradict commonly reported adverse behavioral effects of theophylline.
  • Further research may be needed to reconcile these findings with existing literature.
Abstract